Biologics manufacturing and nonclinical services
Active Awarded Last action
- Contract number
- 75N95022D00022
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $10,736 obligated
Award facts
- Opportunity
-
- 75N95022R00013 Solicitation number
- Combined order value
- $10,736 Current and potential, with all options
- Last date to order 51% complete
- IDV ceiling <1% used
- $149,200,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to Leidos, Inc. as a multiple award contract to provide manufacturing and nonclinical services in support of developing therapeutic biotechnology products for neurological-related disorders. Valued at up to $149.2 million, the contract has a performance period through September 2030. Under the master contract, Leidos has been issued a $10,736.20 firm fixed price delivery order for a contract kickoff meeting and project management plan, to be performed in Herndon, Virginia over a two-month period. This contract supports the Institute's mission to conduct and fund research to understand, diagnose, treat, and prevent neurological disorders and stroke. Leidos, a global technology and engineering solutions provider, will leverage its expertise in areas like scientific program management and technical research to execute task orders for the federal agency.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Contract kickoff meeting and project management plan | National Institute on Drug Abuse (NIH) | $10,736 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95022D00022?
75N95022D00022 was awarded to Leidos, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 28, 2022.
How much is contract 75N95022D00022 worth?
Orders under 75N95022D00022 have obligated $10,736. 75N95022D00022's own ceiling is $149,200,000.
How many orders have been placed under contract 75N95022D00022?
1 order has been placed under 75N95022D00022, the latest on September 30, 2022.
Which agency awarded contract 75N95022D00022?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022D00022, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Who can order from contract 75N95022D00022?
75N95022D00022 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N95022D00022 part of a contract vehicle?
Yes. 75N95022D00022 is part of Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders.
Was contract 75N95022D00022 competed?
The extent of competition for 75N95022D00022 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV